Abeona Therapeutics ABEO
NASDAQ ABEO
$2.60 +0.18 (+7.44%)
At close: Nov 16, 2026 · 4:00 PM EST

Abeona Therapeutics (ABEO) Cash from Discontinued Operations (2021 - 2022)

Updated

Abeona Therapeutics' Cash from Discontinued Operations was -$9.01 million in Q2 2022, compared with -$11.49 million a year earlier.

Analysis

Abeona Therapeutics (ABEO) Cash from Discontinued Operations (2021 - 2022) Analysis & Trends

On a trailing twelve-month basis, Abeona Therapeutics' Cash from Discontinued Operations was -$47.77 million through Jun 30, 2022.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 6.56 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Abeona Therapeutics 149.28 Mn -492.16 Mn 7.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 -9.01 Mn
Mar 31, 2022 -13.69 Mn
Jun 30, 2021 -11.49 Mn
Mar 31, 2021 -13.59 Mn
API Access

Abeona Therapeutics Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=ABEO&period=max&api_key=YOUR_API_KEY